跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Murozine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Murozine
Approved
STANDARD
Murozine
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a73e03a8effc2b47
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
a73e03a8effc2b47
Drug Approval Philippines Name
Murozine
Product Name
Murozine
Registration Number
DRP-3493-07
Brand Name
Murozine
Generic Name
Multivitamins + Buclizine Hydrochloride
Dosage Form
Syrup
Dosage Strength
Formulation Each 5mL syrup contains: Retinol Acetate (Vitamin A)-2000IU Cholecalciferol (Vitamin D3)-200IU Alpha Tocopheryl Acetate (Vitamin E)-1IU Ascorbic Acid (Vitamin C)-60mg Niacinamide-18mg Buclizine Hydrochloride-5mg D-Panthenol-3mg Thiamine Hydrochloride (Vitamin B1)-1mg Riboflavin 5-Phosphate Sodium (Vitamin B2)-1mg Pyridoxine Hydrochloride (Vitamin B6)-1mg Cyanocobalamin (Vitamin B12)-1mcg
Manufacturer
Lloyd Laboratories, Inc.
Trader
D.B. Manix International, Inc.
Distributor
Vispomed Enterprises
Issuance Date
28 June 2021
Expiry Date
28 February 2026
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a73e03a8effc2b47
Type
Standard
Back to Philippines FDA Approvals